EQS-Adhoc: Redcare Pharmacy raises again full-year 2026 revenue guidance driven by strong Rx momentum in Germany
Werte in diesem Artikel
|
EQS-Ad-hoc: Redcare Pharmacy N.V. / Key word(s): Forecast / Full year Werbung
Redcare Pharmacy raises again full-year 2026 revenue guidance driven by strong Rx momentum in Germany Sevenum, the Netherlands, September 28, 2026. Redcare Pharmacy N.V. announces that it is raising its full-year 2026 guidance for the second time this year, driven by continued strong Rx revenue momentum in Germany. The Company now expects:
Werbung Contact: Irina Zhurba Investor Relations Redcare Pharmacy End of Inside Information
28-Sep-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Redcare Pharmacy N.V. |
| Erik de Rodeweg 11-13 | |
| 5975 WD Sevenum | |
| Netherlands | |
| Phone: | 0800 - 200 800 300 |
| Fax: | 0800 - 90 70 90 20 |
| E-mail: | investors@redcare-pharmacy.com |
| Internet: | www.redcare-pharmacy.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y072 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX |
| LEI Code: | 529900JK6UXHY1YKZ082 |
| EQS News ID: | 2406332 |
| End of Announcement | EQS News Service |
|
|
2406332 28-Sep-2026 CET/CEST
Ausgewählte Hebelprodukte auf Redcare Pharmacy (ex Shop Apotheke)
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Redcare Pharmacy (ex Shop Apotheke)
Der Hebel muss zwischen 2 und 20 liegen
